Annexon, Inc.·4

Jun 15, 4:15 PM ET

Yednock Ted 4

4 · Annexon, Inc. · Filed Jun 15, 2026

Research Summary

AI-generated summary of this filing

Updated

Annexon (ANNX) EVP Ted Yednock Exercises 30,646 Options

What Happened

  • Ted Yednock, EVP & Chief Innovation Officer of Annexon (ANNX), exercised options to acquire 30,646 shares on 2026-06-11 at an exercise price of $1.85 per share, costing $56,698.
  • The filing also reports a simultaneous disposition/conversion of 30,646 shares at $0.00 (derivative). Because the acquired and disposed share counts match, the report shows no net increase in shares held.

Key Details

  • Transaction date: 2026-06-11; Form 4 filed: 2026-06-15 (filed within the normal reporting window).
  • Exercise details: 30,646 shares acquired at $1.85 each = $56,698 (transaction code M = option exercise).
  • Disposition: 30,646 shares reported disposed/conversion at $0.00 (derivative line), resulting in net zero new shares reported.
  • Footnote: F1 — the optioned shares were fully vested and exercisable.
  • Shares owned after the transaction are not provided in the summary data; however, the equal acquire/dispose entries indicate no net change in reported shares.

Context

  • For option exercises, simultaneous disposition of the same shares is commonly seen when shares are withheld or surrendered to cover the exercise price and/or taxes (a cashless exercise or withholding). The filing here shows that pattern (acquire + immediate disposition), but does not detail the exact withholding purpose.
  • This is a routine insider exercise of vested options and does not, by itself, indicate a buy or sell market signal.

Insider Transaction Report

Form 4
Period: 2026-06-11
Yednock Ted
EVP & CHIEF INNOVATION OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2026-06-11$1.85/sh+30,646$56,698184,807 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1]
    2026-06-1130,6460 total
    Exercise: $1.85Exp: 2026-08-11Common Stock (30,646 underlying)
Footnotes (1)
  • [F1]The shares subject to the option are fully vested and exercisable.
Signature
/s/ Jennifer Lew, Attorney-in-Fact|2026-06-15

Documents

1 file
  • 4
    form4-06152026_040601.xmlPrimary